Keywords: b-ms, presents, jia, drug, qol, data, acr
B-MS presents JIA drug QOL data at ACR
Article | 03 November 2008
US drug major Bristol-Myers Squibb presented data showing that its Orencia (abatacept) significantly improved multiple aspects of health-related quality of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
